Source: Annual Congress 2004 - Primary care: asthma, allergy and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. H. Strijbos, G. A. P. M. Hentenaar, H. J. L. Brackel (Drachten, Lieshout, Eindhoven, The Netherlands). Asthma treatment and exacerbation rate in daily practice. Eur Respir J 2004; 24: Suppl. 48, 634

Member's Comments

No comment yet.

Related content which might interest you: Use of beta-agonist therapy prior to hospital attendance for severe exacerbations of asthma Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Asthma control, symptoms and exacerbations across treatment levels in patients with asthma Source: Annual Congress 2013 –Management of respiratory diseases in primary care Year: 2013 Hospitalization rate as a measure of the outpatient management quality in children with asthma Source: International Congress 2015 – More paediatric asthma and allergy Year: 2015 Physician consultation and outcomes of treatment in exacerbations of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 559s Year: 2003 The parameters that may affect inhalation therapy success in elderly COPD and asthma patients Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 Impact of roflumilast treatment on the rate and duration of exacerbations and overall steroid load in patients with COPD Source: Annual Congress 2011 - COPD management Year: 2011 Predictors of 90 day readmission in hospitalized patients for asthma exacerbation Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Clinical evaluation of fluticasone/formoterol twice daily delivered via a single dose dry powder inhaler in patients with persistent asthma Source: International Congress 2016 – Asthma management Year: 2016 Prevalence of asthma and management of exacerbations in general practice (GP) after computerised Spanish guideline on the management of asthma (GEMA) and collaborative care environment Source: International Congress 2015 – Management of asthma and COPD in primary care Year: 2015 Effects of switching inhaled medication from twice a day to once a day in patients with bronchial asthma Source: International Congress 2016 – Asthma points to ponder Year: 2016 Respiratory effectiveness group study: Predictors of frequent severe asthma exacerbations Source: International Congress 2015 – Management of asthma and COPD in primary care Year: 2015 Safety of sputum monitoring in a severe asthma population - The Manchester severe asthma team experience Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Blood eosinophils, exacerbations in the previous year, lung function and ICS dose predict frequent exacerbations in asthma Source: International Congress 2016 – Phenotyping asthma Year: 2016 Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment? Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Predictors of severe asthma exacerbations, poor asthma control and beta-agonist overuse in adult asthma Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Comparing pharmacist time use for asthma and COPD patients using various types of inhaler devices Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Finding asthmatics suitable for omalizumab therapy in a district hospital Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013 Budesonide/formoterol maintenance and reliever therapy in adolescent patients with asthma Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 Assessing the risk of future severe asthma exacerbations using CARAT questionnaire and lung function Source: Annual Congress 2013 –Lung function tests to monitor airway diseases Year: 2013 Erdosteine oral treatment of hospitalised COPD exacerbation prolongs time to first re-exacerbation Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases Year: 2014